NexGel, Inc Common Stock
NXGLNexGel, Inc. is a biotechnology company specializing in developing proprietary hydrogel-based delivery systems for wound care and tissue regeneration applications. The company's innovative platforms aim to improve healing processes and enhance patient outcomes through advanced biomedical solutions.
Company News
NEXGEL reported stable Q3 2025 revenue of $2.9 million, improved gross profit margins, and narrowed adjusted EBITDA losses. The company signed new partnerships, launched product lines, and received non-dilutive financing from Stada, positioning for potential growth in Q4.
NEXGEL, Inc. announced it will report its financial results for the first quarter of 2025 on May 13, 2025. The company will host a conference call at 4:30 p.m. ET on the same day to discuss the results.
The article discusses several stocks to watch heading into Tuesday, including Helen of Troy, NEXGEL, SMART Global Holdings, DigitalOcean, and Kura Sushi USA. It provides details on the expected earnings and revenue for these companies.
NEXGEL, a manufacturer of hydrogel products, reported a 20% year-over-year increase in Q2 2024 revenue and projected significant revenue growth in the next two quarters. The company attributed the strong performance to new partnerships and robust demand for its Silly George brand.
